公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 FRESENIUS HEMOCARE BRASIL LTDA.取消

118 记录

产品持有公司班级有效性
Gamma P1 Blood Group Substance10154450187FRESENIUS HEMOCARE BRASIL LTDA.I现有
Gamma Lewis Blood Group Substance10154450188FRESENIUS HEMOCARE BRASIL LTDA.I现有
RED BLOOD CELL (RBC) STORAGE SOLUTION10154450189FRESENIUS HEMOCARE BRASIL LTDA.I现有
Gamma-Quin10154450190FRESENIUS HEMOCARE BRASIL LTDA.I现有
Família de Capture-R Ready-Screen (3)10154450191FRESENIUS HEMOCARE BRASIL LTDA.III20/08/2028
CorQC Test System10154450192FRESENIUS HEMOCARE BRASIL LTDA.III20/08/2028
FAMÍLIA DE CONTROLES CAPTURE-R10154450193FRESENIUS HEMOCARE BRASIL LTDA.III20/08/2028
Família CorQC EXTEND10154450194FRESENIUS HEMOCARE BRASIL LTDA.III27/08/2028
Família WB CorQC10154450195FRESENIUS HEMOCARE BRASIL LTDA.III27/08/2028
DAT Positive Control Cell10154450196FRESENIUS HEMOCARE BRASIL LTDA.III24/09/2028
Família Gamma-clone Anti-Jka e Anti-Jkb10154450197FRESENIUS HEMOCARE BRASIL LTDA.IV28/01/2029
Weak D Cells10154450198FRESENIUS HEMOCARE BRASIL LTDA.III01/04/2029
CATSmart Sistema Contínuo de Autotransfusão10154450199FRESENIUS HEMOCARE BRASIL LTDA.III10/06/2029
CompoSeal Slim10154450200FRESENIUS HEMOCARE BRASIL LTDA.I现有
Compomat G5 Plus10154450201FRESENIUS HEMOCARE BRASIL LTDA.II现有
Gamma EGA Kit10154450202FRESENIUS HEMOCARE BRASIL LTDA.I现有
GammaZyme-B10154450203FRESENIUS HEMOCARE BRASIL LTDA.I现有
H.P.C. Human Platelet Concentrate10154450204FRESENIUS HEMOCARE BRASIL LTDA.I现有
Complement Control Cells10154450205FRESENIUS HEMOCARE BRASIL LTDA.III18/01/2031
Família de Soros Raros Policlonais Immucor10154450206FRESENIUS HEMOCARE BRASIL LTDA.IV03/05/2031
Anti k (Monoclonal) (IgG) Gamma-clone10154450207FRESENIUS HEMOCARE BRASIL LTDA.IV19/07/2031
FMH RapidScreen10154450208FRESENIUS HEMOCARE BRASIL LTDA.IV29/11/2031
Suporte para coleta de medula óssea10154450209FRESENIUS HEMOCARE BRASIL LTDA.I现有
CompoLab TM10154450210FRESENIUS HEMOCARE BRASIL LTDA.II现有
BioR flex - filtros para remoção de leucócitos (beira leito)10154450211FRESENIUS HEMOCARE BRASIL LTDA.III13/06/2032

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家